Chromosome 3

Chromosome 3 : G-banding, diagram and R-banding - Claude Léonard, Jean-Loup Huret

Chromosome 3 diagrams ISCN 2009 - Courtesy Nicole Chia

Alteration Genes Involved Chr/Band Chr/Band References
t(1;3)(p36;q21)RPN1::PRDM161 p363 q21 Link to Pubmed
t(1;3)(p36;q21)PSMD2::PRDM161 p363 q21 Link to Pubmed
t(1;3)(p32;p21)TCTA::TAL11 p323 p21 Link to Pubmed
t(1;3)(q25;q27)GAS5::BCL61 q253 q27 Link to Pubmed
t(1;3)(p36;p21)1 p363 p21 Link to Pubmed
t(2;3)(p12;q27) IGK::BCL62 p123 q27 Link to Pubmed
t(2;3)(p23;q21)TFG::ALK2 p233 q21 Link to Pubmed
t(2;3)(p16;q26)BCL11A::MECOM2 p163 q26 Link to Pubmed
t(2;3)(p21;q26)THADA::MECOM2 p213 q26 Link to Pubmed
t(2;3)(p15-23;q26-27)?::MECOM2 p15-233 q26-27 Link to Pubmed
del(3)(q27q27) ST6GAL1::BCL63 q27 q27 Link to Pubmed
inv(3)(p24q26)?::MECOM3 p24q26 Link to Pubmed
inv(3)(q21q26)RPN1::MECOM3 q21q26 Link to Pubmed
i(3)(q10) in non-Hodgkins lymphoma (NHL)3 q10 Link to Pubmed
3q27 rearrangements (BCL6) in non Hodgkin lymphomat(3;Var)(q27;Var) in non Hodgkin lymphoma3 q27 Link to Pubmed
+3 or trisomy 3 in non Hodgkins lymphoma (NHL)3 Link to Pubmed
inv(3)(p12q26)?::MECOM3 p12q26 Link to Pubmed
inv(3)(q23q26)?::MECOM3 q23q26 Link to Pubmed
inv(3)(q21q26)RPN1::MECOM3 q213 q26 Link to Pubmed
t(3;3)(q21;q26)RPN1::MECOM3 q213 q26 Link to Pubmed
ins(3;3)(q26;q21q26)RPN1::MECOM3 q213 q26 Link to Pubmed
t(3;3)(q27;q29)TFRC::BCL63 q273 q29 Link to Pubmed
3q21q26 rearrangements (RPN1::MECOM) in treatment related leukemiaRPN1::MECOM3 q213 q26 Link to Pubmed
t(3;3)(q27;q28)EIF4A2::BCL63 q273 q28 Link to Pubmed
t(3;3)(q25;q27)MBNL1::BCL63 q253 q27 Link to Pubmed
der(3)t(3;3)(p25-26;q12-21)3 p25-263 q12-21 Link to Pubmed
dup(3)(q12q12):t(3;3)(q12;q12)ADGRG7::TFG3 q123 q12 Link to Pubmed
t(3;3)(q27;q27) ST6GAL1::BCL63 q273 q27 Link to Pubmed
t(3;3)(p24;q26)?::MECOM3 p243 q26 Link to Pubmed
t(3;4)(q27;p13)RHOH::BCL63 q274 p13 Link to Pubmed
t(3;4)(p21;q34)3 p214 q34 Link to Pubmed
t(3;5)(q26;q31)H2AFY::MECOM3 q265 q31 Link to Pubmed
t(3;5)(p21;q32)RBM6::CSF1R3 p215 q32 Link to Pubmed
t(3;5)(q25;q34)NPM1::MLF13 q255 q34 Link to Pubmed
t(3;5)(q21;q31)3 q215 q31 Link to Pubmed
t(3;5)(q26;q34)?::MECOM3 q265 q34 Link to Pubmed
t(3;6)(q27;p21)SRSF3::BCL63 q276 p21 Link to Pubmed
t(3;6)(q27;p22)HIST1H4I::BCL63 q276 p22 Link to Pubmed
t(3;6)(q27;p21)PIM1::BCL63 q276 p21 Link to Pubmed
t(3;6)(q27;q14)SNHG5::BCL63 q276 q14 Link to Pubmed
t(3;6)(q27;p21)3 q276 p21 Link to Pubmed
t(3;6)(q27;q15)?::BCL63 q276 q15 Link to Pubmed
t(3;6)(q25;q26)?::MECOM3 q256 q26 Link to Pubmed
t(3;7)(q27;p12)IKZF1::BCL63 q277 p12 Link to Pubmed
t(3;7)(q27;q32)MIR29A::BCL63 q277 q32 Link to Pubmed
t(3;7)(q27;q32)FRA7H::BCL63 q277 q32 Link to Pubmed
t(3;7)(q26;q21)CDK6::MECOM3 q267 q21 Link to Pubmed
t(3;7)(q26;q21)MECOM::CDK63 q267 q21 Link to Pubmed
t(3;8)(p25;q24)3 p258 q24 Link to Pubmed
t(3;8)(q27;q24)BCL6::MYC3 q278 q24 Link to Pubmed
t(3;8)(q21;q24) in myeloid malignancies3 q218 q24 Link to Pubmed
t(3;8)(q26;q24)PVT1::MECOM3 q268 q24 Link to Pubmed
dic(3;9)(p14;p13)PAX5::FOXP13 p149 p13 Link to Pubmed
t(3;9)(q27;p13)GRHPR::BCL63 q279 p13 Link to Pubmed
t(3;9)(q26;p23)?::MECOM3 q269 p23 Link to Pubmed
t(3;9)(q27;p24)DMRT1::BCL63 q279 p24 Link to Pubmed
t(3;9)(p13;q34.1)FOXP1::ABL13 p139 q34.1 Link to Pubmed
t(3;11)(q27;q23)POU2AF1::BCL63 q2711 q23 Link to Pubmed
t(3;11)(q21;q23)KMT2A::EEFSEC3 q2111 q23 Link to Pubmed
t(3;11)(q26;p15)?::MECOM3 q2611 p15 Link to Pubmed
t(3;11)(q29;p15)NUP98::IQCG3 q2911 p15 Link to Pubmed
t(3;11)(p25;p15)ANKRD28::NUP983 p2511 p15 Link to Pubmed
t(3;11)(q12;p15)NUP98::LNP13 q1211 p15 Link to Pubmed
t(3;11)(p21;q23)KMT2A::NCKIPSD3 p2111 q23 Link to Pubmed
t(3;11)(q25;q23)KMT2A::GMPS3 q2511 q23 Link to Pubmed
t(3;11)(q13.13;q23)KMT2A::KIAA15243 q13.1311 q23 Link to Pubmed
t(3;11)(p11;p15)NUP98::POU1F13 p1111 p15 Link to Pubmed
t(3;11)(q28;q23)KMT2A::LPP3 q2811 q23 Link to Pubmed
t(3;12)(q27;p13)GAPDH::BCL63 q2712 p13 Link to Pubmed
t(3;12)(q27;p12)LRMP::BCL63 q2712 p12 Link to Pubmed
t(3;12)(q26;q21)?::MECOM3 q2612 q21 Link to Pubmed
t(3;12)(q26;p13) ETV6::MECOM3 q2612 p13 Link to Pubmed
t(3;12)(q26;p13) ETV6::EVI13 q2612 p13 Link to Pubmed
t(3;13)(q27;q14)LCP1::BCL63 q2713 q14 Link to Pubmed
t(3;14)(q27;q32)HSP90AA1::BCL63 q2714 q32 Link to Pubmed
t(3;14)(p14;q32)IGH::FOXP13 p1414 q32 Link to Pubmed
t(3;14)(q27;q32) IGH::BCL63 q2714 q32 Link to Pubmed
t(3;14)(q21;q32)3 q2114 q32 Link to Pubmed
t(3;16)(q27;p11)IL21R::BCL63 q2716 p11 Link to Pubmed
t(3;16)(q27;p13)CIITA::BCL63 q2716 p13 Link to Pubmed
t(3;16)(q21;q22)3 q2116 q22 Link to Pubmed
t(3;17)(q26;q12-21)TBL1XR1::RARA3 q2617 q12-21 Link to Pubmed
t(3;17)(q26;q22)?::MECOM3 q2617 q22 Link to Pubmed
t(3;18)(q26;q11)?::MECOM3 q2618 q11 Link to Pubmed
t(3;19)(q27;q13)NAPA::BCL63 q2719 q13 Link to Pubmed
t(3;21)(q26;q22)RUNX1::MECOM3 q2621 q22 Link to Pubmed
t(3;21)(q26;q11)NRIP1::MECOM3 q2621 q11 Link to Pubmed
t(3;21)(p12;q22)RUNX1::?3 p1221 q22 Link to Pubmed
t(3;21)(q26;q22) RUNX1::MECOM in treatment related leukemiaRUNX1::MECOM3 q2621 q22 Link to Pubmed
t(3;22)(q27;q11) IGL::BCL63 q2722 q11 Link to Pubmed